ADRB2 and vascular neoplasm: Another limitation of our study is that we used skin and muscle as control, and they have low expression of β-AR, probably VH could be better control, however, using be this strategy we ensure that we assessed uniformly the β-AR expression in all vascular tumors without losing the data of the VH.